SANTA CLARA, Calif.--(BUSINESS WIRE)--Appvance, the leader in AI-driven software test automation, today announced the issuance of U.S. Patent No. 12,353,317 for “Methods for Creating Test Scripts ...

LUND, Sweden, Aug. 2, 2024 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the pancreatic cancer diagnostics company, today announces the company has filed a US provisional patent application to ...

A small Cleveland-based software company has won the right to a wide-ranging patent that covers online testing, in a move that could have broad ramifications for Internet testing businesses. But ...

SAN DIEGO--(BUSINESS WIRE)--AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company, announced today ...

Rulings in patent ownership disputes have provided useful guidance on how China’s courts interpret the determination of rights, explains Ruo Cao and Mengxuan Zhang of China Patent Agent (HK) Ltd. With ...

Appvance, the leader in AI-driven software test automation, today announced the issuance of U.S. Patent No. 12,353,317 for “Methods for Creating Test Scripts and/or Updating a Model of an Application.

In the most recent episode of IP Innovators, host Steve Brachmann sits down with Stephanie Curcio, CEO and co-founder of NLPatent, to unpack how AI is reshaping prosecution, search, and the overall ...

As an initial disclaimer, Irwin IP LLP is privileged to be lead counsel for LKQ Corporation and Keystone Automotive Industries, Inc. (collectively, “LKQ”) in several design patent validity disputes, ...

LKQ Corp. v. GM Global Technology Operations LLC has brought attention to the ongoing debate surrounding design patent law, particularly with respect to the Rosen-Durling test for design patent ...

LONDON and PHOENIX, Ariz., Sept. 13, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, ...

An en banc panel of the Federal Circuit will soon decide whether to amend its long-standing framework for assessing design patent obviousness, known as the 'Rosen-Durling' test. The forthcoming ...